Potential polymorphic CYP1A2 and CYP2D6-mediated pharmacokinetic interactions between risperidone or olanzapine and selected drugs intended to treat COVID-19
Angel T. Alvarado, Ariana Rojas-Macetas, Geraldine Medalla-Garro, María Saravia, Ricardo Losno, Milton Valderrama-Wong, Ricardo Pariona